⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ASND News
Ascendis Pharma A/S American Depositary Shares
New Two-Year Data from Pivotal ApproaCH Trial Showing Durable Benefits of TransCon® CNP (Navepegritide) in Children with Achondroplasia Shared at ACMG 2026
globenewswire.com
ASND
New Two-Year Data from Pivotal ApproaCH Trial Showing Durable Benefits of TransCon® CNP (Navepegritide) in Children with Achondroplasia Shared at ACMG 2026
globenewswire.com
ASND
Liberty All-Star® Growth Fund, Inc. February 2026 Monthly Update
businesswire.com
NVDA
AAPL
GOOGL
MSFT
META
AMZN
CW
OLLI
AVGO
LGN
MPWR
ARTV
ASND
LLY
NVT
CAT
FTAI
LOW
PLTR
TKO
PINS
UNH
Pharma Leaders Discuss Managing Revenue Management System Updates at Model N Rainmaker Panel Hosted by RevSavvy
prnewswire.com
GILD
ASND
ABBV
Ascend Named the Accounting Automation Partner for Combined Agents of America (CAA)
prnewswire.com
ASND
Ascendis Pharma to Participate in the TD Cowen 46th Annual Health Care Conference
globenewswire.com
ASND
FDA Approves Once-Weekly YUVIWEL® (navepegritide) for Children with Achondroplasia Aged 2 Years and Older
globenewswire.com
ASND
More Than 30 Million Americans Living with Rare Diseases
prnewswire.com
AMGN
SNY
AGIO
ASND
DVA
INCY
NVS
PFE
REGN
UCB
Liberty All-Star® Growth Fund, Inc. January 2026 Monthly Update
businesswire.com
ASG
NVDA
AAPL
GOOGL
MSFT
AMZN
META
OLLI
STEP
CW
ARTV
ASND
MPWR
SMTC
VSEC
PEN
BRO
NVT
EXPE
FITB
MAR
MS
STRD
AMD
BAC
GRMN
NTRA
ORCL
The Boston Globe to Host Rare Disease Summit
prnewswire.com
AZN
ASND
BMRA